Can aged Camellia oleifera Abel oil truly be used to treat atopic dermatitis?
- Xi-Lin Ouyang 1, Zhang-Lin Yuan 1, Xiao-Bing Chen 1, Hong-Wan Gan 2, Sen-Hui Guo 1, Juan Cai 1, Jing-Jing Zhong 2
- 1Department of Pharmacy, Gannan Healthcare Vocational College, Ganzhou, China.
- 2Department of Dermatology, Ganzhou People's Hospital, Ganzhou, China.
- 0Department of Pharmacy, Gannan Healthcare Vocational College, Ganzhou, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Aged Camellia oleifera oil effectively alleviates atopic dermatitis symptoms in mice by improving skin barrier function. Its major fatty acids bind to filaggrin, suggesting a therapeutic mechanism for this traditional remedy.
Area Of Science
- Dermatology
- Pharmacology
- Biochemistry
Background
- Atopic dermatitis is a chronic inflammatory skin disease with symptoms like erythema and pruritus.
- Aged Camellia oleifera oil is traditionally used to treat atopic dermatitis symptoms, but lacks scientific validation.
- The efficacy of aged Camellia oleifera oil in alleviating atopic dermatitis requires scientific investigation.
Purpose Of The Study
- To investigate the therapeutic effects of aged Camellia oleifera oil on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in a mouse model.
- To identify the active metabolites in aged Camellia oleifera oil and elucidate their mechanism of action.
- To assess the binding affinity of key metabolites to filaggrin, a crucial protein for skin barrier integrity.
Main Methods
- Induction of atopic dermatitis in mice using DNCB, followed by topical application of aged Camellia oleifera oil.
- Assessment of skin inflammation through ear thickness measurements, histological examination (HE staining), and serum inflammatory factor analysis (ELISA for IL-4, IgE, IFN-γ, TNF-α).
- Metabolomic analysis of aged Camellia oleifera oil and molecular docking simulations to evaluate the binding of major fatty acids to filaggrin.
Main Results
- Aged Camellia oleifera oil significantly ameliorated DNCB-induced atopic dermatitis symptoms in mice.
- Histological analysis and reduced levels of inflammatory markers (IL-4, IgE, IFN-γ, TNF-α) confirmed the anti-inflammatory effects.
- Forty-one metabolites were identified, with oleic acid, palmitic acid, and stearic acid showing strong binding affinity to filaggrin through molecular docking.
Conclusions
- Aged Camellia oleifera oil demonstrates significant therapeutic potential for alleviating atopic dermatitis symptoms.
- Fatty acids, particularly oleic, palmitic, and stearic acids, are likely the key active components responsible for the oil's efficacy.
- The mechanism involves improving skin barrier function by interacting with filaggrin, reducing water loss, and enhancing skin hydration.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

